- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÀÛ¼ºÀÏ
- 2010-03-05
- Á¶È¸
- 3839
´ëÇÑ Ç÷¾×ÇÐȸ ´Ù¹ß¼º°ñ¼öÁ¾ ¿¬±¸È¸´Â Á¦ 6 Â÷ ASH Review¸¦ ¾Æ·¡¿Í °°ÀÌ °³ÃÖÇÕ´Ï´Ù.
ÀϽà : 2010³â 3¿ù 12ÀÏ(±Ý) 16:30 ~ 19:30
Àå¼Ò : ½Å¶óÈ£ÅÚ º»°ü 3 ÃþÀÇ ¶óÀ϶ô Ȧ
¸¹Àº Âü¼®À» ¹Ù¶ø´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
l ÀϽÃ: 2010³â 3¿ù 12ÀÏ (±Ý) 16:30 ~ 19:30
l Àå¼Ò: ¼¿ï ½Å¶óÈ£ÅÚ º»°ü 3Ãþ ¶óÀ϶ô Ȧ
ÀÏÁ¤
16:30
Session 1 Chair: À̵¿¼ø (¼¿ïÀÇ´ë)
16:40 ~ 17:05 Pathophysiology and pre-clinical studies – ±èÅ¿µ (¼¿ïÀÇ´ë)
Session 2 Chair: ÀÌÀçÈÆ (°¡ÃµÀÇ´ë), ¹Îâ±â (°¡Å縯ÀÇ´ë)
17:10 ~ 17:35 Frontline treatment for non-transplantation candidates – ±è¹Î°æ (¿µ³²ÀÇ´ë)
17:40 ~ 18:05 Frontline treatment for Transplantation candidates – ±è°æÇÏ (¼øõÇâÀÇ´ë)
Session 3. Chair : À±¼º¼ö (¼¿ïÀÇ´ë), ÀÌÁ¦Áß (Àü³²ÀÇ´ë)
18:30 ~ 18:55 Treatment for Relapsed/ Refractory disease - ¹ÚÀº°æ(Áß¾ÓÀÇ´ë)
19:00 ~ 19:25 Supportive care, myeloma bone disease ¹× ±âŸ – ÀÓÈ£¿µ (ÀüºÏÀÇ´ë)
Closing Remark : Á¶°æ»ï (°æÈñÀÇ´ë)
19:30
ÁÖÃÖ: ´ëÇÑÇ÷¾×ÇÐȸ ´Ù¹ß¼º°ñ¼öÁ¾ ¿¬±¸È¸
ÈÄ¿ø: Çѱ¹¼¼¿¤Áø, Çѱ¹¾á¼¾